Reducing symptoms of depression and anxiety in adolescents with inflammatory bowel disease in order to improve quality of life and the clinical course of disease

Reducing symptoms of depression and anxiety in adolescents with inflammatory bowel disease in order to improve quality of life and the clinical course of disease - Healthy Approach to Physical&Psychological problems in Youngsters with IBD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON44382

Enrollment

100

Registered

2014-08-20

Start date

2014-09-29

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

angststoornissen Inflammatory Bowel Disease (IBD) / Chronic bowel inflammation

Interventions

A disease specific CBT program called PASCET-PI (Primary and Secondary Control Enhancement Training - Physical Illness). This program focuses on reduction of depression and anxiety specific in young

Eligibility

Age

2 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Patients between 10-25 years with diagnosed IBD -Informed consent or assent by patients and (if necessary) parents

Exclusion criteria

Exclusion criteria: voor screeningsfase: • IBD patients with parental report of mental retardation • IBD patients receiving psychopharmacological treatment (antidepressants or benzodiazepines) for anxiety of depression • No mastery of the Dutch language • IBD patients with diagnosed Bipolar disorder, Schizophrenia/psychotic disorder, Autism spectrum disorders, Obsessive-compulsive disorder, Posttraumatic stress disorder/Acute stress disorder, or Substance use disorder • Physician reported substance abuse (alcohol, drugs) in the past month • Parental report of Selective mutism • IBD patients already participating in an (psychological of psychopharmacological) intervention study • Current psychological treatment • 8 sessions of protocolled cognitive behavioral therapy during the last year ;voor inclusie in RCT: -IBD patients with scores for a major depressive disorder or an anxiety disorder -IBD patients with a urgent need for immediate referral because of other psychological or behavioral problems than depression or anxiety

Design outcomes

Primary

Measure	Time frame
Main outcome is reduction in symptoms of depression.	—

Secondary

Measure	Time frame
Secondary psychological outcomes are reduction in symptoms of anxiety, quality of life, psychosocial functioning, illness perception, cognitive coping, quality of sleep, parental anxiety and/or depression, stressful life-events, family functioning and demographic factors. Secondary medical outcomes are presence of clinical relapse, IBD activity scores, necessity of surgical intervention, treatment adherence, health care utilization, disease phenotype, treatment strategy, immune status (RNA expression profiles) and immunological activity (blood lymfocyt profiles).	—

Measure

Time frame

Secondary psychological outcomes are reduction in symptoms of anxiety, quality of life, psychosocial functioning, illness perception, cognitive coping, quality of sleep, parental anxiety and/or depression, stressful life-events, family functioning and demographic factors. Secondary medical outcomes are presence of clinical relapse, IBD activity scores, necessity of surgical intervention, treatment adherence, health care utilization, disease phenotype, treatment strategy, immune status (RNA expression profiles) and immunological activity (blood lymfocyt profiles).

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)